Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose chemotherapy regimens for retreated pulmonary tuberculosis
ChiCTR2100048701Phase 4Completed
- Sponsor
- Beijing Chest Hospital
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of isoniazid, rifampicin, ethambutol, pyrazinamide, streptomycin and 1 more in pulmonary tuberculosis (TB) (5 arms), sponsored by Beijing Chest Hospital. Primary endpoints: cure rate, default rate and 4 more. Started Jul 2021; status: completed.
02
Drugs
isoniazidrifampicinethambutolpyrazinamidestreptomycin
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on ChiCTR2100048701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048701.